Navigation Links
Intellect Neurosciences, Inc. to Present at 10TH Annual BIO Investor Forum
Date:10/19/2011

>

Currently, the company is focused on developing next generation antibody therapeutics.  Its most advanced internal candidate is a humanized monoclonal antibody drug conjugate being developed for age-related macular degeneration and other diseases and conditions caused by beta amyloidosis.  For more information, please visit www.intellectns.com.

About The BIO Investor Forum

The 10th Annual BIO Investor Forum is an international investor conference focused on private and emerging public biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.  In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and established biotechnology companies.

Safe Harbor Statement Regarding Forward-Looking Statements:

The statements in this release and oral statements made by representatives of Intellect relating to matters that are not historical facts (including, without limitation, those regarding future performance or financial results, the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Intellect's product candidates and the sufficiency of Intellect's cash and other capital resources) are forward-looking statements that involve risks and uncertainties, including, but not limited to, the likelihood that actual performance or results could materially differ, that future research will prove successful, the likelihood that any product in the research pipeline will receive regulatory approval in the United States or abroad, or Intellect's ability to fund such efforts with or without partners. Intellect undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date her
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
2. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
3. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
4. Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing
5. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
6. BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool
7. Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property
8. Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
9. Veteran Intellectual Property Team Joins Brown Rudnick
10. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
11. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... BlueInGreen® announced the addition of ... bring the world’s most efficient gas dissolution technology to all of Florida, excluding ... the industrial and municipal markets. With offices located in Sarasota, Sebring and Melbourne ...
(Date:7/27/2015)... ... July 27, 2015 , ... Visual Assay was named as a finalist for ... innovative technologies and services of the past year. More than 70 judges selected the ... winners will be announced at the 2015 R&D 100 Awards Dinner on November 13 ...
(Date:7/24/2015)... 2015 Equity Research Institute has ... (NASDAQ: PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ... Biotherapeutics Inc. (NASDAQ: NWBO ), and Acorda Therapeutics ... PDL BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI ... at 5,146.41, down 0.49%, the Dow Jones Industrial Average ...
(Date:7/24/2015)... China , July 24, 2015 ... manufacturing platform , Expands product offering for chronic ... unmet medical needs in diabetes-related complications and dermatology ... 3SBio Inc., (HKEX:1530) ("3SBio" or ,the Company"), a leading ... researching, developing, manufacturing and marketing biopharmaceutical products, today announced ...
Breaking Biology Technology:BlueInGreen Brings Water Treatment Technology to Florida 2Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 53SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4
... Reportlinker.com announces that a new market research report ... Gene Therapy - technologies, markets and companies ... Summary Gene therapy can be ... material to specific target cells of a patient ...
... Nov. 30, 2011  Rhythm announced today that Lex Van ... Scientific Officer. Dr. Van der Ploeg brings to Rhythm ... obesity, metabolic diseases, and other therapeutic areas. ... of the metabolic pathways we are targeting with our ...
... 2011 Reportlinker.com announces that a new ... catalogue: Animal Biotechnology - ... http://www.reportlinker.com/p0203534/Animal-Biotechnology---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology Summary ... evaluates animal biotechnology and its application in ...
Cached Biology Technology:Gene Therapy - Technologies, Markets and Companies 2Gene Therapy - Technologies, Markets and Companies 3Gene Therapy - Technologies, Markets and Companies 4Gene Therapy - Technologies, Markets and Companies 5Gene Therapy - Technologies, Markets and Companies 6Gene Therapy - Technologies, Markets and Companies 7Gene Therapy - Technologies, Markets and Companies 8Gene Therapy - Technologies, Markets and Companies 9Gene Therapy - Technologies, Markets and Companies 10Gene Therapy - Technologies, Markets and Companies 11Gene Therapy - Technologies, Markets and Companies 12Gene Therapy - Technologies, Markets and Companies 13Gene Therapy - Technologies, Markets and Companies 14Gene Therapy - Technologies, Markets and Companies 15Gene Therapy - Technologies, Markets and Companies 16Gene Therapy - Technologies, Markets and Companies 17Gene Therapy - Technologies, Markets and Companies 18Gene Therapy - Technologies, Markets and Companies 19Gene Therapy - Technologies, Markets and Companies 20Gene Therapy - Technologies, Markets and Companies 21Rhythm Names Lex Van der Ploeg Chief Scientific Officer 2Animal Biotechnology - Technologies, Markets and Companies 2Animal Biotechnology - Technologies, Markets and Companies 3Animal Biotechnology - Technologies, Markets and Companies 4Animal Biotechnology - Technologies, Markets and Companies 5Animal Biotechnology - Technologies, Markets and Companies 6Animal Biotechnology - Technologies, Markets and Companies 7Animal Biotechnology - Technologies, Markets and Companies 8Animal Biotechnology - Technologies, Markets and Companies 9Animal Biotechnology - Technologies, Markets and Companies 10Animal Biotechnology - Technologies, Markets and Companies 11Animal Biotechnology - Technologies, Markets and Companies 12Animal Biotechnology - Technologies, Markets and Companies 13Animal Biotechnology - Technologies, Markets and Companies 14
(Date:7/23/2015)... DUBLIN , July 23, 2015 ... the addition of the "Global Outlook of ... their offering. The global biometrics ... both public and commercial applications owing to the ... will witness a transformation that enhances the growth ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... good, but sometimes its better to be lucky. Ecologist ... St. Louis, had just completed a census of snakes at ... flood of 1993 deluged the area, putting the preserve at ... with a rare opportunity: His collected data and the flood ...
... have developed tools to help solve two of the main ... to quickly test stem cell response to different drugs or ... viable stem cells to study from only a few available ... of stems cells on devices the size of a standard ...
... several repeat operations as they grow, since the since ... for bigger ones. Researchers at Childrens Hospital Boston have ... the lab from a patients own cells. In ... describe making pulmonary valves through tissue engineering. These valves, ...
Cached Biology News:Ecologist finds dire devastation of snake species following floods of '93, '95 2Ecologist finds dire devastation of snake species following floods of '93, '95 3Ecologist finds dire devastation of snake species following floods of '93, '95 4Putting stem cell research on the fast track 2Putting stem cell research on the fast track 3Putting stem cell research on the fast track 4A step toward tissue-engineered heart structures for children 2
One-step, microplate or cuvet, colorimetric, detection range 0.3 g/dL to 5 g/dL. Procedure: 5 min....
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
One-step, microplate or cuvet, colorimetric, detection range 0.04% to 4%. Procedure: 30 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
Biology Products: